Drug profile · INN
cabotegravir
VOCABRIA
cabotegravir (VOCABRIA) is a human immunodeficiency virus type 1 integrase inhibitor. Associated with ViiV Healthcare Pty Ltd. Route of administration: intramuscular. Current US regulatory status: approved.
Drug details — cabotegravir
- US status
- approved
- Class
- Antiinfectives for systemic use (J05)
- Route
- INTRAMUSCULAR
- Patents
- 0
- Programs
- 2
- Data quality
- 0.84
Quick answer
cabotegravir (VOCABRIA) is a human immunodeficiency virus type 1 integrase inhibitor. Associated with ViiV Healthcare Pty Ltd. Route of administration: intramuscular. Current US regulatory status: approved.
Key facts
Mechanism of action
Human immunodeficiency virus type 1 integrase inhibitor
Primary target: Human immunodeficiency virus type 1 integrase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
| TGA | approved | — |
Recent coverage
KRX IR Reference : Executive Summary Plan for SCD NDR (ENG, Jun 2026)
This page should frame the KRX English IR reference as a company disclosure/investor-relations document and give readers a concise way to navigate its purpose and likely themes. Keep the summary factual and avoid adding performance or product claims not present in the source.
HIV Treatment Clinical Trials Africa: Long-Acting Injectables & AMA Pathways
This article delves into HIV treatment clinical trials in Africa, highlighting long-acting injectables and the AMA pathways for enhanced patient care.
FDA Approves Apretude: First Injectable PrEP for HIV Prevention
Apretude has been approved by the FDA as the first injectable PrEP for HIV prevention, providing a groundbreaking option for those at risk of infection.
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is cabotegravir?
cabotegravir (VOCABRIA) is a human immunodeficiency virus type 1 integrase inhibitor. Associated with ViiV Healthcare Pty Ltd. Route of administration: intramuscular. Current US regulatory status: approved.
What is the brand name for cabotegravir?
VOCABRIA is a marketed brand name for cabotegravir. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of cabotegravir?
cabotegravir has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.